Stock Research: Kobayashi Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Kobayashi Pharmaceutical

TSE:4967 JP3301100008
23
  • Value
    13
  • Growth
    53
  • Safety
    Safety
    88
  • Combined
    53
  • Sentiment
    20
  • 360° View
    360° View
    23
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

KOBAYASHI PHARMACEUTICAL CO., LTD. is a drug manufacturer that offers health care, daily necessities, skin care, dietary supplements, and other products through its Domestic Household Products Manufacturing and Sales, Overseas Household Products Manufacturing and Sales, and Mail Order segments. In the last fiscal year, the company had a market cap of $2716 million, profits of $557 million, revenue of $1054 million, and 3615 employees.

more
Index
SDG 12
SDG 13
SDG 3
SDG 5
SDG 8
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 8-Jan-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
13 19 18 7
Growth
53 44 37 37
Safety
Safety
88 75 92 83
Sentiment
20 15 63 30
360° View
360° View
23 27 42 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
33 25 41 29
Opinions Change
50 40 83 50
Pro Holdings
n/a 27 72 42
Market Pulse
16 5 38 51
Sentiment
20 15 63 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
13 19 18 7
Growth
53 44 37 37
Safety Safety
88 75 92 83
Combined
53 44 33 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
19 23 22 19
Price vs. Earnings (P/E)
22 26 34 23
Price vs. Book (P/B)
37 36 38 22
Dividend Yield
48 49 44 18
Value
13 19 18 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
36 43 28 32
Profit Growth
57 71 35 45
Capital Growth
75 7 75 82
Stock Returns
31 57 23 23
Growth
53 44 37 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
94 97 94 88
Refinancing
47 44 61 53
Liquidity
94 82 94 90
Safety Safety
88 75 92 83

Similar Stocks

Discover high‑ranked alternatives to Kobayashi Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Maruha Nichiro

TSE:1333
Country: Japan
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

KOSÉ

TSE:4922
Country: Japan
Industry: Personal Products
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: